Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 21294119)

1.

Genetic changes in tumour microenvironments.

Campbell I, Qiu W, Haviv I.

J Pathol. 2011 Mar;223(4):450-8. doi: 10.1002/path.2842. Epub 2011 Jan 17. Review.

PMID:
21294119
2.

Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution.

Campbell I, Polyak K, Haviv I.

Cancer Res. 2009 Sep 1;69(17):6765-8; discussion 6769. doi: 10.1158/0008-5472.CAN-08-4253. Epub 2009 Aug 25. Erratum in: Cancer Res. 2009 Oct 1;69(19):7894.

3.

Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations.

Hosein AN, Wu M, Arcand SL, Lavallée S, Hébert J, Tonin PN, Basik M.

Cancer Res. 2010 Jul 15;70(14):5770-7. doi: 10.1158/0008-5472.CAN-10-0673. Epub 2010 Jun 22.

4.

Molecular genetics of small cell lung carcinoma.

Wistuba II, Gazdar AF, Minna JD.

Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13. Review.

PMID:
11479891
5.

Alterations of tumor suppressor genes in bladder cancer.

Cordon-Cardo C, Reuter VE.

Semin Diagn Pathol. 1997 May;14(2):123-32. Review.

PMID:
9179973
6.
7.

Molecular biology of colorectal cancer.

Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J.

Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. Review.

PMID:
9438104
8.

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.

Burt EC, James LA, Greaves MJ, Birch JM, Boyle JM, Varley JM.

Br J Cancer. 2000 Aug;83(4):467-72.

9.

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.

Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, Simon W, Mürdter TE, Aulitzky WE.

BMC Cancer. 2008 Dec 11;8:364. doi: 10.1186/1471-2407-8-364.

10.

Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.

Stindl R.

Med Hypotheses. 2008;71(1):126-40. doi: 10.1016/j.mehy.2008.01.010. Epub 2008 Feb 21.

PMID:
18294777
11.

Somatic stem cells and the origin of cancer.

Martínez-Climent JA, Andreu EJ, Prosper F.

Clin Transl Oncol. 2006 Sep;8(9):647-63. Review.

PMID:
17005467
12.

Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis.

Bischoff FZ, Heard M, Simpson JL.

J Reprod Immunol. 2002 May-Jun;55(1-2):49-64.

PMID:
12062821
13.

Genetic pathways of two types of gastric cancer.

Tahara E.

IARC Sci Publ. 2004;(157):327-49. Review.

PMID:
15055305
14.

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.

Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS.

J Pathol. 2010 Apr;220(5):562-73. doi: 10.1002/path.2675.

PMID:
20099298
16.

Generation of phenotypic diversity and progression in metastatic tumor cells.

Nicolson GL.

Cancer Metastasis Rev. 1984;3(1):25-42. Review.

PMID:
6370418
17.

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.

Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, Scharwächter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.

Br J Dermatol. 2005 Jan;152(1):43-51.

PMID:
15656799
18.

TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.

Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC.

IARC Sci Publ. 2004;(157):247-70. Review.

PMID:
15055300
19.

Aneuploidy, the somatic mutation that makes cancer a species of its own.

Duesberg P, Rasnick D.

Cell Motil Cytoskeleton. 2000 Oct;47(2):81-107. Review.

PMID:
11013390
20.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk